Cyclacel Pharmaceuticals shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Cyclacel Pharmaceuticals (CYCC) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Cyclacel Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Cyclacel Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cyclacel Pharmaceuticals by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $33 | 33 | 1.00 |
| 2024-06-30 | $53 | 33 | 1.61 |
| 2024-03-31 | $85 | 40 | 2.14 |
| 2023-12-31 | $104 | 39 | 2.67 |